No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
Norris Medicines Ltd. focuses on the development and production of pharmaceutical compounds, medicinal chemicals, and botanical extracts. Their diverse product range addresses various health concerns, encompassing categories like antibiotics, anti-inflammatory agents, anti-emetics, nutritional supplements, cough and cold remedies, dermatological and allergy treatments, anti-malarial drugs, and medications for diabetic and cardiac conditions. The company, which established its operations in 1990, is based in Ankleshwar, India.
www.norrispharma.comNo one on the platform currently holds NORRIS.BO.
No tracked institution reports a position in NORRIS.BO as of their last filing.
No one on the platform has traded NORRIS.BO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| NORRIS.BONorris Medicines Limited | $16.77 | +4.94% | $168M | — |
| BERLDRG.BOBeryl Drugs Limited | $23.97 | +3.14% | $122M | — |
| CHCL.BOCian Healthcare Limited | $5.01 | +0.00% | $125M | — |
| CHEMOPH.BOChemo Pharma Laboratories Limited | $130.85 | +0.00% | $196M | — |
| EMMESSA.BOEmmessar Biotech & Nutrition Limited | $24.60 | +4.24% | $123M | — |
| EVOQ.BOEvoq Remedies Ltd. | $1.49 | -0.67% | $37M | — |
| NOVATEOR.BONovateor Research Laboratories | $35.10 | +9.69% | $212M | — |
Source: Financial Modeling Prep · peers by sector/industry